PRESS RELEASE published on 11/12/2024 at 13:00, 4 months 25 days ago EV Nickel Reports Precious Metals Assays Associated with Elevated Nickel Mineralization in Hole Ev24-Car08 on the CarLang C Zone EV Nickel Inc. announces significant nickel mineralization with high PGM values in CarLang C area, indicating potential for magmatic sulphide source. Exploration and testing programs ongoing Exploration Program EV Nickel Inc. Nickel Mineralization PGM Values CarLang C Area
BRIEF published on 11/07/2024 at 07:35, 5 months ago APONTIS PHARMA Reports Revenue Growth in 9M 2024 Amid Revised Forecast Revenue Growth Financial Forecast APONTIS PHARMA Single Pill Combinations Novartis Collaboration
BRIEF published on 11/07/2024 at 07:35, 5 months ago APONTIS PHARMA annonce une croissance de son chiffre d'affaires sur les 9 premiers mois de 2024 malgré des prévisions révisées APONTIS PHARMA Prévisions Financières Croissance Des Revenus Combinaisons De Pilules Simples Collaboration Avec Novartis
PRESS RELEASE published on 11/07/2024 at 07:30, 5 months ago APONTIS PHARMA reports profitable revenue growth for Single Pill combinations in 9M 2024 – revenue guidance adjusted APONTIS PHARMA reports profitable revenue growth for Single Pill combinations in 9M 2024, with revenue guidance adjusted. Novartis collaboration boosts revenues. Full-year forecast slightly lowered Revenue Growth APONTIS PHARMA Single Pill Combinations Full-year Forecast Novartis Collaboration
BRIEF published on 10/30/2024 at 16:25, 5 months 8 days ago APONTIS PHARMA's Boards Recommend Acceptance of Zentiva's Tender Offer Tender Offer APONTIS PHARMA Shareholder Recommendation Financial Premium Zentiva
BRIEF published on 10/30/2024 at 16:25, 5 months 8 days ago Les conseils d'administration d'APONTIS PHARMA recommandent l'acceptation de l'offre publique d'achat de Zentiva Offre Publique D'achat APONTIS PHARMA Prime Financière Zentiva Recommandation Aux Actionnaires
PRESS RELEASE published on 10/30/2024 at 16:20, 5 months 8 days ago Management Board and Supervisory Board of APONTIS PHARMA AG recommend accepting Zentiva’s public tender offer Management Board and Supervisory Board of APONTIS PHARMA AG recommend accepting Zentiva's public tender offer. Offer price of EUR 10.00 per share represents a premium. Acceptance period ends on 21 November 2024 Acquisition Tender Offer APONTIS PHARMA AG Recommendation Zentiva
PRESS RELEASE published on 10/18/2024 at 13:37, 5 months 20 days ago Original-Research: APONTIS PHARMA AG (von Montega AG): Halten (zuvor: Kaufen) Zentiva bietet öffentliches Erwerbsangebot für APONTIS PHARMA zu 10 EUR an. Montega AG stuft Empfehlung von Kauf auf Halten um. Analyse der Übernahme und finanziellen Auswirkungen Montega AG Aktien Finanzanalyse Zentiva Übernahmeangebot
BRIEF published on 10/16/2024 at 12:00, 5 months 22 days ago APONTIS PHARMA et Zentiva concluent un partenariat stratégique Offre Publique D'achat APONTIS PHARMA Croissance Pharmaceutique Partenariat Zentiva Stratégie De La Pilule Unique
BRIEF published on 10/16/2024 at 12:00, 5 months 22 days ago APONTIS PHARMA and Zentiva Forge Strategic Partnership APONTIS PHARMA Public Purchase Offer Pharmaceutical Growth Zentiva Partnership Single Pill Strategy
Published on 04/07/2025 at 18:00, 1 hour 47 minutes ago BrooQLy Inc. (BRQL) dba Dynamic Aerospace Systems Acquires Assets of Vayu (US) Inc., Impossible Aerospace Corporation, and Global Autonomous Corporation from Alpine 4 Holdings (ALPP) for $14,990,000
Published on 04/07/2025 at 14:30, 5 hours 17 minutes ago Newsmax Enters into Standby Equity Purchase Agreement of Up to $1.2 Billion With Yorkville Advisors
Published on 04/07/2025 at 14:30, 5 hours 17 minutes ago Sparta Provides Update on Delay in Filing Annual Financial Statements
Published on 04/07/2025 at 14:00, 5 hours 47 minutes ago NOA Lithium Advances Towards 2025 Water Exploration at Rio Grande Project
Published on 04/07/2025 at 19:00, 47 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 31 MARS 2025 au 04 AVRIL 2025
Published on 04/07/2025 at 19:00, 47 minutes ago u-blox Divests Dual Mode Cellular-Satellite Communications Business to Trident IoT
Published on 04/07/2025 at 18:53, 53 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/07/2025 at 18:06, 1 hour 41 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 04/07/2025 at 18:00, 1 hour 47 minutes ago EUROPLASMA: EXERCICE DU QUATRIÈME INVESTOR CALL
Published on 04/07/2025 at 19:00, 47 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/07/2025 at 19:00, 47 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES MARS 2025
Published on 04/07/2025 at 19:00, 47 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/07/2025 at 19:00, 47 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES MARS 2025
Published on 04/07/2025 at 18:00, 1 hour 47 minutes ago SMTPC - Communiqué sur la mise à disposition du Rapport annuel 2024